Principal Scientific Advisor of NuclearMediX and inventor of the Fluoroethyl-triazole Octreotate ([18F]FET-βAG-TOCA, FETO) SSTR-PET tracer. Prof. Aboagye is a Fellow of the Academy of Medical Sciences (FMedSci) and Professor of Cancer Pharmacology & Molecular Imaging at Imperial College London. With over 15 years of pioneering research, he has 16 patents and 378 published articles, successfully translating multiple radiopharmaceutical drugs into clinical trials.